Priority Date: 17.08.01 (US 20010313137P)

Complement pathway inhibitors binding to C5 and C5a without preventing the formation of C5b

  • Application ID: EP07008202
  • Status: The patent has been granted


Technology company logo small
Technology Company


no operation time available
Headquarter in London and 5 offices
active in Legal Services and Matchmaking and Trading
Employment test 1001 - 5000 employees
Company dna jones day
operating since 1893
Headquarter in Cleveland and 38 offices
active in Legal Services


This EP application has the IPC combination A61, C07, and C12. Jones Day and Mathys & Squire LLP are specialized in the combination A61, C07, and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 124 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.


  • 17.08.2001 - Priority Date (US 20010313137P)
  • 16.01.2008 - Publication A2 (EP1878441)
  • 10.09.2008 - Publication A3 (EP1878441)
  • 24.01.2018 - Publication B1 (EP1878441)